1,213
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors

, , , , &
Pages 302-310 | Received 19 Oct 2009, Accepted 10 Feb 2010, Published online: 20 Jul 2011

References

  • Danziger RS. Aminopeptidase N in arterial hypertension. Heart Fail Rev 2008; 13:293–298.
  • Dixon J, Kaklamanis L, Turley H, Hickson ID, Leek RD, Harris AL, Gatter KC. Expression of aminopeptidase-N (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol 1994;47:43–47.
  • Zhang R, Hua G, Andacht TM, Adang MJ. A 106-kDa aminopeptidase is a putative receptor for Bacillus thuringiensis Cry11Ba toxin in the mosquito Anopheles gambiae. Biochemistry 2008;47:11263–11272.
  • Uehara N, FuJita M, Shimizu T. Colorimetric assay of aminopeptidase N activity based on inhibition of the disassembly of gold nano-composites conjugated with a thermo-responsive copolymer. Anal Sci 2009;25:267–273.
  • Bauvois B, Dauzonne D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations and therapeutic prospects. Med Res Rev 2006;26:88–130.
  • Fukasawa K, FuJii H, Saitoh Y, Koizumi K, Aozuka Y, Sekine K, Yamada M, Saiki I, Nishikawa K. Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis. Cancer Lett 2006;243:135–143.
  • Xu W, Li Q. Progress in the development of aminopeptidase N (APN/CD13) inhibitors. Curr Med Chem AntiCancer Agents 2005;5:281–301.
  • Onohara Y, NakaJima Y, Ito K, Xu Y, Nakashima K, Ito T, Yoshimoto T. Crystallization and preliminary X-ray characterization of aminopeptidase N from Escherichia coli. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006;62:699–701.
  • Ito K, NakaJima Y, Onohara Y, Takeo M, Nakashima K, Matsubara F, Ito T, Yoshimoto T. Crystal structure of aminopeptidase N (Proteobacteria alanyl aminopeptidase) from Escherichia coli and conformational change of methionine 260 involved in substrate recognition. J Biol Chem 2006;281:33664–33676.
  • Addlagatta A, Gay L, Matthews BW. Structure of aminopeptidase N from Escherichia coli suggests a compartmentalized, gated active site. Proc Natl Acad Sci USA 2006;103:13339–13344.
  • Addlagatta A, Gay L, Matthews BW. Structural basis for the unusual specificity of Escherichia coli aminopeptidase N. Biochemistry 2008;47:5303–5311.
  • Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W. Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors. Bioorg Med Chem 2009;17:4666–4673.
  • Yang K, Wang Q, Su L, Fang H, Wang X, Gong J, Wang B, Xu W. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors. Bioorg Med Chem 2009;17:3810–3817.
  • Nishizawa R, Saino T, Takita T, Suda H, Aoyagi T. Synthesis and Structure-Activity Relationships of Bestatin Analogues, Inhibitors of Aminopeptidase B. J Med Chem 1977;20:510–515.
  • Jordis U, Sauter F, Siddiqi SM. Synthesis of (1S,4S)-2-thia-5-azabicyclo[2.2.1]heptane. Indian J Chem Sec B 1989;28:294–296.
  • Kim S, Lee JI, Kim YC. A simple and mild esterification method for carboxylic acids using mixed carboxylic-carbonic anhydrides. J Org Chem 1985;50:560–565.
  • Baragi VM, Shaw BJ, Renkiewicz RR, Kuipers PJ, Welgus HG, Mathrubutham M, Cohen JR, Rao SK. A versatile assay for gelatinases using succinylated gelatin. Matrix Biol 2000;19:267–273.
  • Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W. Bioorg Med Chem 2008;16:5473–5481.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.